Australian Injecting & Illicit Drug Users League (AIVL), January 2017
This booklet aims to increase knowledge and awareness of hepatitis C, allowing drug users to make informed decisions regarding their health. Produced by drug users for drug users, as part of a harm reduction, peer-based approach to health.
Download booklet (PDF) here
Pregnancy Outcome Unit, SA Health: November 2016 The Pregnancy Outcome Unit undertakes statewide monitoring of pregnancy characteristics and outcomes to identify population groups most at risk and determine preventive interventions. This is undertaken through data collections. Each year, the Pregnancy Outcome Unit publishes two annual reports. Pregnancy Outcome in South Australia provides annual...
Kirby Institute/UNSW – 21 February 2017
More Australians were treated for their hepatitis C infection in the first year new generation hepatitis C regimens were made available on the Pharmaceutical Benefits Schemes than in the past decade, according to a new report released today by the Kirby Institute at UNSW Sydney.
Read more here
Download report (PDF) here
ASHM, ongoing The Hepatitis B Mapping Project aims to facilitate a comprehensive understanding of chronic hepatitis B (CHB) in Australia. The data and analysis can be used to inform targeted awareness and intervention campaigns to suit the particular local needs of people living with CHB and those providing services to them. The Project is a joint initiative of ASHM and the Doherty Institute...
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, July 2016 Chronic hepatitis C virus (HCV) infection is a major public health challenge for Australia, affecting approximately 230,000 people who are at risk of progressive liver fibrosis leading to cirrhosis, liver failure and hepatocellular carcinoma (HCC). The burden of liver disease due to HCV is projected to triple by...
nam/aidsmap, 19 April 2016 There is a very high incidence of hepatitis C virus (HCV) re-infection among HIV-positive men who have sex with men (MSM) in western Europe, according to research presented to the International Liver Congress in Barcelona. Investigators found that a quarter of HIV-positive MSM who cleared an initial HCV infection were re-infected with HCV within three years. The...